Does Dr. SHAYLA BERGMANN have financial conflicts of interest?

Dr. SHAYLA BERGMANN (MD) has received a total of $214,231 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $203,710 in personal promotional payouts (consulting, meals, travel) and $10,521 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SHAYLA BERGMANN?

According to CMS Open Payments data, Dr. SHAYLA BERGMANN received funding from NOVO NORDISK ($184,082), GENZYME CORPORATION ($8,877), and PFIZER ($7,500).

Does Dr. SHAYLA BERGMANN receive research grants or speaking fees?

Dr. SHAYLA BERGMANN has received $203,710 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $10,521 in clinical research grants.

DR. SHAYLA BERGMANN

MDReal-Time Hydrated

Specialty: Pediatrics, Pediatric Hematology-Oncology

Practice Location: BEAUFORT, SC 29902

NPI Number: 1730143645

LIFETIME INDUSTRY VALUE

$214,231

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BERGMANN is a verified Pediatrics, Pediatric Hematology-Oncology practitioner based in BEAUFORT, SC.

Between 2021 and 2024, Dr. BERGMANN had an overall industry promotional and research financial footprint of $214,231 as recorded in the federal CMS Open Payments database.

$203,710 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$10,521 was allocated to sponsored clinical trials and medical research activities.

Dr. BERGMANN's primary funding source is NOVO NORDISK, which accounts for $184,082 (representing 85.9% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVO NORDISK

Rank 1

$184,082

85.9%

GENZYME CORPORATION

Rank 2

$8,877

4.1%

PFIZER

Rank 3

$7,500

3.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.